Position in ALNY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$12,459,240
New position
Shares Held
37,656
first reported quarter
Ownership
0.028%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026M&G PLC holds $145,893,196 across 13 Biotechnology names. ALNY ranks #5 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
138,163 | $41,030,266 | |
| 2 | INSM |
INSMED Inc
|
98,221 | $16,061,097 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
91,339 | $15,438,117 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
226,541 | $12,797,301 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
37,656 | $12,459,240 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
138,567 | $12,051,171 | |
| 7 | TARS |
Tarsus Pharmaceuticals, Inc.
|
166,364 | $11,670,434 | |
| 8 | ARQT |
Arcutis Biotherapeutics, Inc.
|
469,082 | $11,051,571 |
All Filings in ALNY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,459,240 | 37,656 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||